Literature DB >> 11819513

Establishment and preliminery use of hepatitis B virus preS1/2 antigen assay.

Kun Chen, Bao-Guang Han, Xian-Kai Ma, He-Qiu Zhang, Li Meng, Guo-Hua Wang, Fang Xia, Xiao-Guo Song, Shi-Gan Ling.   

Abstract

Entities:  

Year:  1999        PMID: 11819513      PMCID: PMC4688807          DOI: 10.3748/wjg.v5.i6.550

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  5 in total

1.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

Authors:  A R Neurath; B Seto; N Strick
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

2.  Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.

Authors:  P Coursaget; Y Buisson; C Bourdil; B Yvonnet; C Molinié; M T Diop; J P Chiron; O Bao; I Diop-Mar
Journal:  Res Virol       Date:  1990 Sep-Oct

3.  Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.

Authors:  M A Petit; F Zoulim; F Capel; S Dubanchet; C Dauguet; C Trepo
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

4.  Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication.

Authors:  C Delfini; S Colloca; G Taliani; F Mazzotta; A D'Agata; C Buonamici; T Stroffolini; G Carloni
Journal:  J Med Virol       Date:  1989-07       Impact factor: 2.327

5.  Evaluation of the pre-S (pre-S(1)Ag/pre-S(2)Ab) system in hepatitis B virus infection.

Authors:  M I Galán; J Tomás; M C Bernal; F J Salmerón; M C Maroto
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

  5 in total
  3 in total

1.  Immunogenicity of HGV NS5 protein expressed from Sf9 insect cells.

Authors:  H Ren; F L Zhu; S Y Zhu; Y Song; Z T Qi
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.

Authors:  Xiao-Ju Guan; Xiao-Jun Guan; Yu-Zhang Wu; Zheng-Cai Jia; Tong-Dong Shi; Yan Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.

Authors:  Jun Wei; Yu-Qin Wang; Zhi-Meng Lu; Guang-Di Li; Yuan Wang; Zu-Chuan Zhang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.